semaglutide oral fda approval approves Wegovy pill (oral semaglutide) FDA Approves Oral Semaglutide as

The costeffectiveness of treating patients with no liver fibrosis has been questioned, since the prognosis even without therapy is excellent, further underscoring the importance of accurately staging the severity of liver disease47

Common side effects of GLP-1 medications and how to manage them Side effects are common with GLP-1 medications, especially at the start of treatment or when the dose is increased

WADA lists BPC-157 as prohibited at all times for governed athletes in the S0-Non-Approved Substance category

Cheng FS, Lei JX, Zhang J et al (2025) Global burden of Alzheimer disease and other dementias reveals escalating geographical disparities and metabolic risks: a comprehensive analysis of 1990-2021 data

KATHERINE ARMOUR: It's concerning because so many, particularly young people, of course, do use social media as a common way to research their topics of interest